Spectrum Pharmaceuticals (NASDAQ:SPPI) ("Spectrum" or the "Company"), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug
On Tuesday, the FDA released briefing documents related to Spectrum Pharmaceutical Inc’s (NASDAQ:SPPI) application for poziotinib for treating patients with previously treated…